COVID-19 Diagnostics Market Size, Share & Impact Analysis, By Product (Instruments and Reagents & Kits), By Technology (Polymerase Chain Reaction [PCR], Enzyme-Linked Immunosorbent Assay [ELISA], Lateral Flow Immunoassay [LFIA], and Others), By Sample Type (Oropharyngeal & Nasopharyngeal Swabs, Nasal Swabs, Blood, and Others), By Setting (Lab-Based and Point of Care), By End-user (Hospitals & Clinics, Laboratories & Diagnostic Centers, Home Testing, and Others), and Regional Forecast, 2022-2029

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI103291

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2020-2029
Base Year	2021
Estimated Year	2022
Forecast Period	2022-2029
Historical Period	2020
Unit	Value (USD billion)
Segmentation	By Product Instruments Reagents & Kits
	By Technology Polymerase Chain Reaction (PCR) Enzyme-Linked Immunosorbent Assay (ELISA) Lateral Flow Immunoassay (LFIA) Others
	By Sample Type Oropharyngeal & Nasopharyngeal Swabs Nasal Swabs Blood
	By Setting Lab-based Point of Care
	By End-user Hospitals & Clinics Laboratories & Diagnostic Centers Home Testing Others
	By Geography North America (U.S. and Canada) Europe (Germany, U.K., France, Italy, Spain, Russia, and Rest of Europe) Asia Pacific (India, Japan, Australia, South Korea, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)